Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus sublingual midazolam for sedation during upper gastrointestinal endoscopy
IRCT20100102002963N36Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of midazolam in None (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Sedation score, Pain/Discomfort score and 1 more. Started Sep 2022; status: completed.
02
Drugs
midazolam
Beyond the preview
Go deeper on IRCT20100102002963N36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002963N36.